Issue

In Part I of this two-part article (Clinical Geriatrics 2006;14[1]:17-25), we reviewed the current literature regarding the epidemiology of atherosclerotic vascular disease (ASVD) in older adults with diabetes mellitus, the mechanisms underlying the pathogenesis of atherosclerosis, and the clinical risk factors associated with the development and progression of ASVD in patients with the metabolic syndrome and diabetes. Part II of this article summarizes treatment guidelines designed to reduce risk and prevent progression of ASVD, and suggests recommendations for their applicability in the olde